Endogenous monoamine oxidase inhibitor-like substances in monkey brain

Biochemical Pharmacology
T EgashiraY Yamanaka

Abstract

The extraction and partial purification of endogenous "monoamine oxidase (MAO) inhibitor-like" material from the monkey brain are described. The endogenous material (F-1 and F-2) obtained after Bio-Gel P-2 gel filtration and silica column chromatography inhibited MAO in the monkey brain mitochondria toward 5-hydroxytryptamine (5-HT), beta-phenylethylamine (beta-PEA), tyramine and dopamine as substrates. The inhibitory effects of F-1 and F-2 were non-linear concentration dependent, and F-1 non-competitively inhibited A-form MAO, while F-2 inhibited A-form MAO competitively and inhibited B-form MAO non-competitively. These substances were more potent inhibitors of A-form than of B-form MAO. F-2 was heat stable but liable to the treatment with pepsin and trypsin. F-1 was not inactivated by heat treatment and digestion with pepsin and trypsin. F-1 may be a low molecular weight (less than 1350) compound, including certain monoamines or their metabolites or other unidentified compounds, while F-2 was a low molecular weight (about 2500) peptide.

References

Jul 2, 1979·Life Sciences·P H Yu, A A Boulton
May 1, 1978·The American Journal of Psychiatry·W H Berrettini, W H Vogel
Mar 1, 1978·Biochemical Pharmacology·M M Asaad, D E Clarke
Oct 1, 1987·Japanese Journal of Pharmacology·T Egashira, Y Yamanaka
Dec 1, 1986·Japanese Journal of Pharmacology·T EgashiraY Yamanaka
May 1, 1972·The American Journal of Psychiatry·D L Murphy, R Weiss
Feb 1, 1984·Japanese Journal of Pharmacology·T EgashiraY Yamanaka
Dec 15, 1984·Biochemical Pharmacology·C T Giambalvo
Jan 1, 1983·Journal of Neural Transmission·L OrelandK Kiianmaa
Dec 1, 1981·Psychiatry Research·H PeturssonM Sandler
Dec 1, 1982·The American Journal of Psychiatry·R E Becker, C T Giambalvo
Nov 9, 1981·Life Sciences·C T Giambalvo, R E Becker
Aug 1, 1981·Acta Psychiatrica Scandinavica·W F GattazH Beckmann
Feb 1, 1980·Biochemical Pharmacology·V GloverM Sandler
Jul 1, 1980·Archives of General Psychiatry·J R DavidsonE J Feuer
Nov 1, 1956·Canadian Journal of Biochemistry and Physiology·J R LAGNADO, T L SOURKES

❮ Previous
Next ❯

Citations

Nov 27, 1991·Biochemical Pharmacology·L Fernandez-NovoaD F Wilson
Feb 1, 1994·Neurochemical Research·S Murphy, A Pastuszko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.